Abstract
Purpose
We have previously demonstrated that 2-methoxyestradiol (2-ME) inhibits the growth of human endometrial cancer HEC-1-A and RL-95-2 cells in vitro. In this study, we examined the effects of 2-ME on human endometrial carcinoma in severe combined immune deficient (SCID) mice. The potential side effects of 2-ME on SCID mice were also investigated.
Methods
Severe combined immune deficient mice were injected with HEC-1-A cells (1 × 106/mouse) and a 18 day administration of 2-ME was followed after 1 week cell implantation. Tumor volume, weight, body weight and blood chemistry were determined. Tumor tissues were examined with an antibody against the proliferative cell nuclear antigen (PCNA) and Ki-67. Liver, spleen, kidney, heart, lung and uterus were screened by pathological examinations.
Results
2-ME (100 mg/kg p.o.) did not inhibit the growth of human endometrial carcinoma as compared to control. Necrotic areas were similar in both 2-ME-treated and -untreated tumor tissues. The expressions of PCNA and Ki-67 were similar in 2-ME-treated and untreated tumor sections. The wet weight of uterus was increased to more than threefold. The epithelial cells and glands in endometrium were increased. No significant difference was detected in blood AST, ALT and BUN.
Conclusions
2-ME has no antitumor effects on human endometrial carcinoma in our animal model. Its proliferative effects on endometrium and uterus might limit its use in gynecological cancers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bu S, Blaukat A, Fu X, Heldin NE, Landstrom M (2002) Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells. FEBS Lett 531(2):141–151
Dingli D, Timm M, Russell SJ, Witzig TE, Rajkumar SV (2002) Promising preclinical activity of 2-methoxyestradiol in multiple myeloma. Clin Cancer Res 8(12):3948–3954
Dubey RK, Gillespie DG, Zacharia LC, Rosselli M, Korzekwa KR, Fingerle J, Jackson EK (2000) Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms. Biochem Biophys Res Commun 278(1):27–33
Dubey RK, Gillespie DG, Zacharia LC, Rosselli M, Imthurn B, Jackson EK (2002) Methoxyestradiols mediate the antimitogenic effects of locally applied estradiol on cardiac fibroblast growth. Hypertension 39(2 Pt 2):412–417
Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L (1994) The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368(6468):237–239
Huober JB, Nakamura S, Meyn R, Roth JA, Mukhopadhyay T (2000) Oral administration of an estrogen metabolite-induced potentiation of radiation antitumor effects in presence of wild-type p53 in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 48(4):1127–1137
Ireson CR, Chander SK, Purohit A, Perera S, Newman SP, Parish D, Leese MP, Smith AC, Potter BV, Reed MJ (2004) Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. Br J Cancer 90(4):932–937
Kameyama K, Takami H, Umemura S, Osamura YR, Wada N, Sugino K, Mimura T, Ito K (2000) PCNA and Ki-67 as prognostic markers in human parathyroid carcinomas. Ann Surg Oncol 7:301–304
Kataoka M, Schumacher G, Cristiano RJ, Atkinson EN, Roth JA, Mukhopadhyay T (1998) An agent that increases tumor suppressor transgene product coupled with systemic transgene delivery inhibits growth of metastatic lung cancer in vivo. Cancer Res 58(21):4761–4765
Kinuya S, Kawashima A, Yokoyama K, Kudo M, Kasahara Y, Watanabe N, Shuke N, Bunko H, Michigishi T, Tonami N (2001) Anti-angiogenic therapy and radioimmunotherapy in colon cancer xenografts. Eur J Nucl Med 28(9):1306–1312
Klauber N, Parangi S, Flynn E, Hamel E, D’Amato RJ (1997) Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 57(1):81–86
LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ, Pribluda VS (2002) 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res 62(13):3691–3697
Li L, Heldin NE, Grawé J, Ulmsten U, Fu X (2004) Induction of apoptosis or necrosis in human endometrial carcinoma cells by 2-methoxyestradiol. Anticancer Res 24(6):3983–3989
Lippert TH, Adlercreutz H, Berger MR, Seeger H, Elger W, Mueck AO (2003) Effect of 2-methoxyestradiol on the growth of methyl-nitroso-urea(MNU) induced rat mammary carcinoma. J Steroid Biochem Mol Biol 84(1):51–56
Miller KD, Murry DJ, Curry E, Haney LG, McClaskey N, Storniolo AM, Phillips E, Pribluda V, Gubish ER, Sledge GW (2002) A phase I study of 2-methoxyestradiol (2ME2) plus docetaxel (D) in patients (pts) with metastatic breast cancer (MBC). Presented at the 38th annual meeting of the American Society of Clinical Oncology, Orlando
Mooberry SL (2003) Mechanism of action of 2-methoxyestradiol: new developments. Drug Resist Updat 6(6):355–361
Nishigaki I, Sasaguri Y, Yagi K (1995) Anti-proliferative effect of 2-methoxyestradiol on cultured smooth muscle cells from rabbit aorta. Atherosclerosis 113(2):167–170
Qadan LR, Perez-Stable CM, Anderson C, D’Ippolito G, Herron A, Howard GA, Roos BA (2001) 2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer. Biochem Biophys Res Commun 285(5):1259–1266
Ryschich E, Werner J, Gebhard MM, Klar E, Schmidt J (2003) Angiogenesis inhibition with TNP-470, 2-methoxyestradiol, and paclitaxel in experimental pancreatic carcinoma. Pancreas 26(2):166–172
Schumacher G, Kataoka M, Roth JA, Mukhopadhyay T (1999) Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines. Clin Cancer Res 5(3):493–499
Sibonga JD, Lotinun S, Evans GL, Pribluda VS, Green SJ, Turner RT (2003) Dose-response effects of 2-methoxyestradiol on estrogen target tissues in the ovariectomized rat. Endocrinology 144(3):785–792
Wassberg E (1999) Angiostatic treatment of neuroblastoma. Ups J Med Sci 104(1):1–24
Zacharia LC, Jackson EK, Gillespie DG, Dubey RK (2001) Catecholamines abrogate antimitogenic effects of 2-hydroxyestradiol on human aortic vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21(11):1745–1750
Acknowledgments
The study was supported financially by the Swedish Medical Research Council, Selanders fund and Family Planning’s fund in Uppsala, Sweden.
Author information
Authors and Affiliations
Corresponding author
Additional information
Founding sources: Swedish Medical Research Council, Selanders fund and Family Planning’s fund.
Rights and permissions
About this article
Cite this article
Li, L., Yu, F., Wu, X. et al. Effects of 2-methoxyestradiol on endometrial carcinoma xenografts. J Cancer Res Clin Oncol 133, 315–320 (2007). https://doi.org/10.1007/s00432-006-0173-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-006-0173-x